Submit your email to push it up the queue
Trianni, Inc., a leading innovator in the biotechnology sector, is headquartered in the United States, with significant operations across North America and Europe. Founded in 2011, the company has established itself as a pioneer in the development of advanced antibody discovery technologies, particularly through its proprietary Trianni Mouse platform. Trianni's core offerings include high-quality monoclonal antibodies that are uniquely engineered for specificity and efficacy, catering to the needs of researchers in pharmaceuticals and diagnostics. The company has achieved notable milestones, including collaborations with major pharmaceutical firms, solidifying its position as a trusted partner in the biopharmaceutical industry. With a commitment to scientific excellence and innovation, Trianni, Inc. continues to drive advancements in therapeutic development and research applications.
How does Trianni, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Trianni, Inc.'s score of 25 is lower than 56% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Trianni, Inc., headquartered in the US, currently does not have specific carbon emissions data available, as indicated by the absence of reported figures. The company is a current subsidiary of AbCellera Biologics Inc., which may influence its climate commitments and reporting practices. While there are no documented reduction targets or climate pledges from Trianni, Inc., it is important to note that the company is part of a broader corporate family that may have its own sustainability initiatives. As such, any climate commitments or emissions data may be inherited from its parent organisation, AbCellera Biologics Inc., which could potentially have its own strategies for addressing carbon emissions. In the absence of specific emissions data or reduction initiatives, Trianni, Inc. is positioned within an industry context that increasingly prioritises sustainability and climate action. The company may benefit from aligning with industry standards and practices to enhance its environmental performance in the future.
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Trianni, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.